... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
... (OSM) is a pleiotropic cytokine produced by activ.... OSM inhibits the growth of some tumour and norma...and Kaposis sarcoma cell proliferation, cytokine r...protein receptor expression on hepatoma cells. Mou...
...syringe pump series combines Harvard Apparatuss be...ce and a wide range of configuration options. A lo...nsions of syringes from all the major manufacturer...e pertinent information from across the lab. All m...
Biology Products:(Date:11/24/2009)... The FBI recently approved the Promega PowerPl...ing in or generating DNA records for the National ...on, WI USA (PRWEB) -- The FBI recently approved th... laboratories participating in, or generating DNA ... NDIS currently contains more than seven million p...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
(Date:11/24/2009)...ovember24/PRNewswire/--HealthRoboticstodayannounce...pofselected,investors.ThisrecentlyformedToronto-ba...nada,Inc.andwillmarket,install,andsupport,HealthRo...,revolutionaryproductofferingsi.v.STATION(TM),i.v....lsoprovideassistanceonan"asneeded,basis"toitsstrat...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CTI...AnnualPiperJaffrayHealthCareConference.Theconferen...el. ,, CTIwillpresentonTuesday,December1at11:00...stofCTI,spresentationwillbeavailableat www.cellthe...terwards. , ,PiperJaffrayHealthCareConference,New...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2